1. Home
  2. HZO vs CGEM Comparison

HZO vs CGEM Comparison

Compare HZO & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HZO
  • CGEM
  • Stock Information
  • Founded
  • HZO 1998
  • CGEM 2016
  • Country
  • HZO United States
  • CGEM United States
  • Employees
  • HZO N/A
  • CGEM N/A
  • Industry
  • HZO Auto & Home Supply Stores
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HZO Consumer Discretionary
  • CGEM Health Care
  • Exchange
  • HZO Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • HZO 499.9M
  • CGEM 482.7M
  • IPO Year
  • HZO 1998
  • CGEM 2021
  • Fundamental
  • Price
  • HZO $26.26
  • CGEM $6.51
  • Analyst Decision
  • HZO Strong Buy
  • CGEM Strong Buy
  • Analyst Count
  • HZO 4
  • CGEM 8
  • Target Price
  • HZO $33.25
  • CGEM $27.25
  • AVG Volume (30 Days)
  • HZO 266.6K
  • CGEM 525.8K
  • Earning Date
  • HZO 10-30-2025
  • CGEM 11-06-2025
  • Dividend Yield
  • HZO N/A
  • CGEM N/A
  • EPS Growth
  • HZO N/A
  • CGEM N/A
  • EPS
  • HZO N/A
  • CGEM N/A
  • Revenue
  • HZO $2,320,257,000.00
  • CGEM N/A
  • Revenue This Year
  • HZO N/A
  • CGEM N/A
  • Revenue Next Year
  • HZO $3.85
  • CGEM N/A
  • P/E Ratio
  • HZO N/A
  • CGEM N/A
  • Revenue Growth
  • HZO N/A
  • CGEM N/A
  • 52 Week Low
  • HZO $16.85
  • CGEM $6.44
  • 52 Week High
  • HZO $37.86
  • CGEM $18.62
  • Technical
  • Relative Strength Index (RSI)
  • HZO 52.89
  • CGEM 36.07
  • Support Level
  • HZO $24.71
  • CGEM $6.44
  • Resistance Level
  • HZO $26.75
  • CGEM $7.82
  • Average True Range (ATR)
  • HZO 1.04
  • CGEM 0.43
  • MACD
  • HZO -0.10
  • CGEM -0.11
  • Stochastic Oscillator
  • HZO 45.71
  • CGEM 5.90

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: